The L’Occitane Group (L’Occitane en Provence, L’Occitane au Brésil, Elemis, Sol de Janeiro, Erobian, Melvita, and so on.) is increasing its at the moment introduced its portfolio with the acquisition of Italian luxurious dwelling perfume model Dr. Vranjes Firenze.

Created in 1983 by Dr. Paolo Vranjes, the Tuscan model markets its merchandise in over 75 international locations by way of a sturdy community together with 28 mono-brand shops and 650 factors of sale. For over 40 years, Dr. Vranjes has been on the forefront of luxurious dwelling scents, with an emphasis on in-house manufacturing and R&D. The model has constantly delivered ‘Made in Florence’ experiences by way of its dwelling diffusers, candles and a rising line of private fragrances which might be destined to grow to be an integral a part of the its portfolio.

With this operation, the quantity of which has not been disclosed, the L’Occitane Group intends to proceed constructing “a geographically balanced portfolio of robust premium magnificence and perfume manufacturers.”

“We’re thrilled to proceed to develop our international model portfolio with the addition of Dr. Vranjes Firenze, which is complementary to our present assortment of premium magnificence and perfume manufacturers, every with a powerful id and a real need to make a distinction,” stated Reinold Geiger, Chairman of the L’Occitane Group.

“Our model has undergone significant development whereas honouring the wealthy heritage of Dr. Vranjes Firenze. It’s with nice pleasure that I hand over the legacy of Dr. Vranjes Firenze to the L’Occitane Group, which is understood for its distinguished heritage and expansive international attain,” added Paolo Vranjes, Founder and Chairman of Dr. Vranjes Firenze.

The completion of the transaction is anticipated on the finish of the primary quarter of 2024.